NYMC Faculty Publications
Evaluation of the Role of Oral Penicillin for Treating Lyme Disease Patients with Erythema Migrans in the United States
DOI
10.1016/j.diagmicrobio.2020.115071
Journal Title
Diagnostic Microbiology and Infectious Disease
First Page
115071
Last Page
115071
Document Type
Article
Publication Date
8-2020
Department
Medicine
Abstract
Clinical trials of oral penicillin preparations in the United States for treating Lyme disease patients with erythema migrans are limited to 2 studies. The results of these studies demonstrated a less than optimal outcome of this treatment. However, there were serious methodologic concerns in both studies precluding the interpretation that phenoxymethylpenicillin specifically should be regarded as ineffective. Therefore, additional clinical trials should be conducted in the United States with close attention to the dose and duration of treatment that have been used very successfully in Europe.
Recommended Citation
Wormser, G. P., & Strle, F. (2020). Evaluation of the Role of Oral Penicillin for Treating Lyme Disease Patients with Erythema Migrans in the United States. Diagnostic Microbiology and Infectious Disease, 97 (4), 115071-115071. https://doi.org/10.1016/j.diagmicrobio.2020.115071
